 |
University of Oklahoma College of Medicine | |
| City: Oklahoma City | State: OK | |
|
Links:
Commentary:COI_University_of_Oklahoma_Health_Sciences_Center__1_.pdf Oklahoma_2009_PharmFree_FacultyADM8.pdf Oklahoma_2009_PharmFree_GME727.pdf Oklahoma_2009_PharmFree_STUAFF322.pdf Most of the policies at this institution somewhat limit the potential for conflicts of interest. The policy on purchasing and formularies is exemplary, as are the limits placed on scholarships for students and trainees. In 2010 policy changes submitted addressed disclosure, samples and enforcement. Policies require annual disclosure but only for financial interests above a certain baseline. The sample policy submitted does not address the use of pharmaceutical and medical device sample distribution by industry representatives and their use amongst patient populations. The policy does, though, clearly list potential sanctions for non-compliance.
This institution submitted updated policies to the 2010 AMSA PharmFree Scorecard, their score remains an C.
This institution's evaluation was last updated: 12/15/2010
|
||
| Gifts & Meals |  |
This policy prohibits all gifts, but allows “modest meals or snacks provided as part of a formal educational program.” |
| Consulting relationships | |
The policy specifies that consultant fees “should be commensurate with the level of service provided.” Additionally, fees should not be accepted for simply attending events or for having loose connections with pharmaceutical companies. |
| Industry-funded speaking relationships | |
Physicians and residents may serve as educational speakers, but must not serve as promotional speakers. |
| Disclosure |  |
All employees required to disclose all financial interests as they arise or at least annually. |
| Pharmaceutical samples | |
No policy submitted. |
| Purchasing & Formularies |  |
Exemplary policy: "Health care professionals who serve on any committees dealing with pharmacy, formulary, equipment or device selection, or clinical practice guidelines shall disclose to the respective committee membership any consulting or sponsoring relationships they have with any commercial entity during the time or their committee service and for two years after termination of the relationship. Such professionals should recuse themselves from any committee decisions which may suggest conflict from their commercial relationship(s)." |
| Industry Sales Representatives | |
Industry sales representatives are only allowed on-site in non-patient care areas by appointment or invitation from a physician or, in the case of medical students, by appointment or invitation from the supervising physician. |
| On-campus Education | |
Industry cannot control speakers/content, but contributions do not need to be at institutional level. |
| Attendance at Industry-Sponsored Lectures & Meetings Off-Campus | |
Financial assistance for off-site education is permitted, but only when attendees are selected by the AMC supervisor and the grants are unrestricted and given directly to the AMC supervising unit, not the attendee. |
| Industry Support for Scholarships & Funds for Trainees | |
The policy prohibits industry from selecting the recipient(s) of scholarships or trainee funds. |
| Medical school curriculum | |
There is no evidence that the medical school curriculum covers industry marketing influence and conflict of interest in a substantial way. |
| Do the policies specify an oversight mechanism? |  |
Oversight clearly stated. |
| Are there explicit sanctions for noncompliance? | |
Sanctions for noncompliance are clearly referenced. |
 | |
 | Model policy |
 | Good progress toward model policy |
 | No policy, or policy unlikely to have a substantial effect on behavior |
 | Did not report |
 | Policy not relevant to this institution (e.g., does not make purchasing decisions) |
